INS and type 2 diabetes mellitus: Women with T2DM who are resistant to insulin may have a drop in estrogen levels, which slightly increases their risk of malignancy in their breasts and may extend to additional organs with high levels of estrogen receptors, such as the endometrium and ovaries (Eketunde, 2020).